A high dose of Novo Nordisk’s obesity drug Wegovy led patients to lose substantial weight in a clinical trial, but still less ...

SAN FRANCISCO — When Eli Lilly last year started offering lower-priced vials of its blockbuster obesity drug Zepbound ... “We’d like to lower the entry cost and we’d like to have more ...

Zepbound is a medicine you can obtain only by prescription, and it's typically used to address obesity and other ...

Weight-loss drugs like Novo Nordisk’s Wegovy and Eli Lilly’s Zepbound are generating billions of dollars in sales Pharma rival Novo Nordisk (NYSE:NVO) was the first to market with its GLP-1 ...

are used in diabetes and obesity drugs like Eli Lilly's Mounjaro and Zepbound. The stock (LLY) dropped 8.2% in morning trading, enough to make it the S&P 500 index's SPX worst performer.

Why it matters: Lilly's growth prospects are driven by Mounjaro and Zepbound, and shortfalls in sales could portend weaker long-term potential for this market. Lilly is positioned to remain the ...

"FDA is aware that some patients and health care professionals may look to unapproved versions ... windy day': Live updates GLP-1 class drugs like Zepbound and Mounjaro form part of a larger ...

Eli Lilly & Co.'s Zepbound ... look at waist-to-height ratio (an assessment of body fat distribution, which is linked to heart disease risk)? Or should they aim for specific health markers, like ...